(Q48441907)

11 February 2018

title

TGF-beta1 potentiates astrocytic nitric oxide production by expanding the population of astrocytes that express NOS-2. (English)

1 reference

11 February 2018

0 references

Mary E Hamby

1

1 reference

11 February 2018

James A Hewett

series ordinal

2

1 reference

11 February 2018

Sandra J Hewett

series ordinal

3

1 reference

11 February 2018

publication date

1 November 2006

1 reference

11 February 2018

published in

Glia

1 reference

11 February 2018

volume

54

1 reference

11 February 2018

page(s)

566-577

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

Broad expression of Toll-like receptors in the human central nervous system

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

Potentiation of oxygen-glucose deprivation-induced neuronal death after induction of iNOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

A detrimental role for nitric oxide synthase-2 in the pathology resulting from acute cerebral injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

TGF-beta1 represses activation and resultant death of microglia via inhibition of phosphatidylinositol 3-kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

Nitric oxide and neuronal and pancreatic beta cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Increased expression of transforming growth factor-beta after cerebral ischemia in the baboon: an endogenous marker of neuronal stress?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Expression of various TGF-beta isoforms and type I receptor in necrotizing human brain lesions.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Cultured astrocytes express toll-like receptors for bacterial products.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Nitric oxide acutely inhibits neuronal energy production. The Committees on Neurobiology and Cell Physiology.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Transforming growth factor-beta and ischemic brain injury

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Transcriptional activation and increase in expression of Alzheimer's beta-amyloid precursor protein gene is mediated by TGF-beta in normal human astrocytes.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Differential activation of astrocytes by innate and adaptive immune stimuli

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Nitric oxide and peroxynitrite cause irreversible increases in the K(m) for oxygen of mitochondrial cytochrome oxidase: in vitro and in vivo studies.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Transforming growth factor-beta: a neuroprotective factor in cerebral ischemia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Molecular profile of reactive astrocytes--implications for their role in neurologic disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Transforming growth factor-betas in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

CD14 mediate endotoxin induction of nitric oxide synthase in cultured brain glial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Hypoxia modulates nitric oxide-induced regulation of NMDA receptor currents and neuronal cell death

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Transforming growth factor beta differentially modulates the inducible nitric oxide synthase gene in distinct cell types

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Regulation of beta-amyloid precursor protein isoform mRNAs by transforming growth factor-beta 1 and interleukin-1 beta in astrocytes.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Characterization of an improved procedure for the removal of microglia from confluent monolayers of primary astrocytes.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Inducible nitric oxide synthase expression in cultures enriched for mature oligodendrocytes is due to microglia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Interferon-gamma and interleukin-1 beta induce nitric oxide formation from primary mouse astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Receptors for neurotransmitters on astrocytes in the mammalian central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

S100beta induces neuronal cell death through nitric oxide release from astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Differential regulation by cytokines of human astrocyte nitric oxide production

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Marked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Immunohistochemical study of the expression of cytokines and nitric oxide synthases in brains of patients with dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Possible involvement of Janus kinase Jak2 in interferon-gamma induction of nitric oxide synthase in rat glial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Inducible nitric oxide synthase (iNOS)-like immunoreactivity in argyrophilic, tau-positive astrocytes in progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Inhibition of LPS-induced iNOS and NO synthesis in primary rat microglial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Regulation of microglial activation by TGF-beta, IL-10, and CSF-1.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

iNOS (NOS2) at a glance

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Nitric oxide and macrophage function

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Opposite regulation of prostaglandin E2 synthesis by transforming growth factor-beta1 and interleukin 10 in activated microglial cultures.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Astrocytes: form, functions, and roles in disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Gene expression profiles of reactive astrocytes cultured from dopamine-depleted striatum.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

New roles for astrocytes: redefining the functional architecture of the brain

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Loss of dopaminergic neurons by the induction of inducible nitric oxide synthase and cyclooxygenase-2 via CD 40: relevance to Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon-gamma-mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Modulation of inducible nitric oxide synthase expression in astroglial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Suppression of interleukin-1beta-induced nitric-oxide synthase promoter/enhancer activity by transforming growth factor-beta1 in vascular smooth muscle cells. Evidence for mechanisms other than NF-kappaB.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Differential astrocyte response to Theiler's murine encephalomyelitis virus infection

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Further evidence for a role of nitric oxide in experimental allergic encephalomyelitis: aminoguanidine treatment modifies its clinical evolution

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

An antiviral mechanism of nitric oxide: inhibition of a viral protease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Induction of nitric oxide synthase during Japanese encephalitis virus infection: evidence of protective role

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Aminoguanidine-induced amelioration of autoimmune encephalomyelitis is mediated by reduced expression of inducible nitric oxide synthase in the spinal cord

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

An inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune myocarditis in Lewis rats

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Induction of nitric oxide synthase in glial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

The role of nitric oxide in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor-beta 1 in astrocytes from distinct brain regions.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Delayed onset and decreased severity of experimental autoimmune uveoretinitis in mice lacking nitric oxide synthase type 2.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Enhanced release of synaptic glutamate underlies the potentiation of oxygen-glucose deprivation-induced neuronal injury after induction of NOS-2.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Analysis of the neuroprotective effects of various nitric oxide donor compounds in murine mixed cortical cell culture.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Differential modulation of prostaglandin H synthase-2 by nitric oxide-related species in intact cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Inhibition of endotoxin-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: a role for transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Control of nitric oxide synthase expression by transforming growth factor-beta: implications for homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Astrocytes, from brain glue to communication elements: the revolution continues

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

NADPH-diaphorase activity in activated astrocytes represents inducible nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Transforming growth factor-beta 1 exhibits delayed gene expression following focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Astroglial overproduction of TGF-beta 1 enhances inflammatory central nervous system disease in transgenic mice .

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Alzheimer's disease-like cerebrovascular pathology in transforming growth factor-beta 1 transgenic mice and functional metabolic correlates

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Inducible nitric oxide synthase expression is selectively induced in astrocytes isolated from adult human brain.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20411

7 January 2021

Identifiers

DOI

10.1002/GLIA.20411

1 reference

11 February 2018

PubMed ID

16921522

1 reference

11 February 2018